Skip to main content

The Government has been Very Supportive on e-Pharmacies

The Government has been Very Supportive on e-Pharmacies
The online pharmacy sector expects regulations to be streamlined by the end of this year, Prashant Tandon, CEO of 1mg and president of the India Internet Pharmacy Association, said in an interview. Edited excerpts:
How has regulation been a pain for e-pharmacy startups? In the last two years, many epharmacies had to shut because they were harassed by the local players. When a drug inspector comes to a vendor he knows only the Drugs and Cosmetics Act. We need to see it in light of the IT Act, which supersedes all other acts in terms of applicability. What we have been asking is that since the IT Act supersedes all other Acts in terms of applicability, all of that needs to be harmonised and communicated though one notification.
On that, the government has taken a very positive stance on that but hasn’t yet introduced any notification. We have been assured that work is in progress towards that. But the local harassment has reduced.What about your demand to be treated at par with offline pharmacies? There are a lot of laws in the Drugs and Cosmetics Act that we comply with but (in reality) these don’t apply to offline pharmacies, which continue to dispense medicines without prescriptions. The law should be uniformly applicable across the board. It should not be the case that because we are following the law
we lose business. What are your main demands? Harmonise all major applicable laws and Acts—definition of marketplaces as per DIPP, the Drugs and Cosmetics Act, and the IT Act. The Drugs and Cosmetics Act needs to be updated so that it is implementable in the online world. We are also demanding that the government mandate the registry of all e-pharmacies. What the US and Europe have done is that only those e-pharmacies that have registered in the country are allowed to sell within the country. We have asked for a similar thing.Also, things like taking a relook at the classification of medicines. Many medicines are under no schedule.
What headway have you achieved? We are in active conversations with multiple departments of the government, including the health ministry, the IT ministry and DIPP. We have been assured that by the end of this year everything will be streamlined. What we have been asking has been accepted in principle at least.The government has been very proactive and supportive. In the Niti Aayog’s three-year road map, e-pharmacy finds mention as something to be clarified by the end of this year. The draft pharmaceutical policy also validates e-phamacy.
How have the regulatory roadblocks hampered growth plans? Initially, it was proposed that epharmacies should have a physical presence in the states they operate in. We have reservations against that proposal. Interstate restrictions defeat a lot of value for customers. We are in almost 600 cities. As of today, we do not do interstate shipments. But that is a value that e-pharmacies can provide. In every state (we operate in) we make shipments through multiple partners
The Mint, New Delhi, 17th October 2017

Comments

Popular posts from this blog

Budget: Startup sector gets new Fund of Funds, FM to allocate Rs 10K cr

  The Indian startup sector received a boost with Finance Minister Nirmala Sitharaman announcing the establishment of a new fund of funds (FoF) in the Budget 2025. The minister unveiled a fresh FoF with an expanded scope, allocating Rs 10,000 crore. The initial fund of funds announced by the government with an investment of Rs 10,000 crore successfully catalysed commitments worth Rs 91,000 crore, the minister said.   “The renewal of the Rs 10,000 crore commitment to the Fund of Funds for alternative investment funds (AIFs) is a significant step forward for the Indian startup and investment ecosystem. The initial Rs 10,000 crore commitment catalysed Rs 91,000 crore in investments, and I fully expect this fresh infusion to attract an additional Rs 1 lakh to Rs 1.5 lakh crore in capital,” said Anirudh Damani, managing partner, Artha Venture Funds.   Damani further added that this initiative will provide much-needed growth capital to early-stage startups, further strengthenin...

After RBI rate cut, check latest home loan interest rates of top banks for loans above Rs 75 lakh

  The Reserve Bank of India (RBI) has reduced the repo rate by 25 basis points from 6.50% to 6.25% in its monetary policy review as announced on February 7, 2025. After the RBI repo rate cut, banks such as SBI, Canara Bank, PNB, and Union Bank among others have cut their repo linked lending rates. Most other banks are also expected to cut their lending rates in line with the RBI rate cut. After banks cut their lending rates, their home loan borrowers will have to pay less interest. Normally, when a lender cuts the lending rate, borrowers get two options: Either to go for a reduction in EMIs or reduce the tenure of the loan. The second option will help the borrowers clear their home loan outstanding faster. In case, the borrower goes for reduction in EMI then the lower lending rate of the lender would mean lower Equated Monthly Installment (EMI) for borrowers.   EMI is the amount you will pay on a specific date each month till the loan is repaid in full.A repo rate-linked home ...

GST collections rise 9.9% to exceed Rs 1.96 trillion in March 2025

  Gross GST collection in March grew 9.9 per cent to over Rs 1.96 lakh crore, government data showed on Tuesday. GST revenue from domestic transactions rose 8.8 per cent to Rs 1.49 lakh crore, while revenue from imported goods was higher 13.56 per cent to Rs 46,919 crore. Total refunds during March rose 41 per cent to Rs 19,615 crore. After adjusting refunds, net GST revenue stood at over Rs 1.76 lakh crore in March 2025, a 7.3 per cent growth over the year-ago period.       - Business Standard 02 th March, 2025